Type-1 Diabetes Patient Decision Simulator for In Silico Testing Safety and Effectiveness of Insulin Treatments
Conclusion: The proposed simulator can be used to perform credible ISCT in realistic insulin treatment scenarios. Significance: The T1D patient decision simulator can be used to reliably assess novel insulin treatmen-
s, e.g., based on use of CGM only, in a realistic multiple-day scenario.
Source: IEEE Transactions on Biomedical Engineering - Category: Biomedical Engineering Source Type: research
More News: Biomedical Engineering | Clinical Trials | Diabetes | Diabetes Type 1 | Endocrinology | Insulin